Connection
Marc Bonaca to Sodium Channel Blockers
This is a "connection" page, showing publications Marc Bonaca has written about Sodium Channel Blockers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.028 |
|
|
|
-
O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol. 2014 Apr 29; 63(16):1644-53.
Score: 0.028